Skip to main content

Day: November 12, 2024

CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the “Stockholders Approve Acquisition of Greenbrook TMS” section, it should say that the Company expects to achieve cash flow breakeven by the third quarter of 2025, not the second. The corrected release follows: Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the third quarter of 2024. Third Quarter 2024 Highlights Third quarter 2024 revenue of $18.5 million, a 4% increase...

Continue reading

Zefiro Methane Corp. Chief Commercial Officer to Serve as Featured Speaker at United Nations COP29

In addition to attending the conference with the Company’s Founder and CEO, Zefiro CCO Tina Reine will be featured as a panelist on a UN COP29 Climate Action Innovation Zone discussion regarding the future of the voluntary carbon marketplace FORT LAUDERDALE, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced that the Company’s Chief Commercial Officer Tina Reine will serve as a featured speaker at the United Nations’ 2024 Climate Change Conference (“COP29”) tomorrow, November 13th, at 3:40 PM GMT+4 in Baku, Azerbaijan. In addition to attending the conference with Zefiro Founder and Chief Executive Officer Talal Debs, Ms. Reine will lend her expertise to a COP29 Climate Action Innovation Zone-sanctioned panel discussion...

Continue reading

Viridian Metals Announces Opening of Trading on TSX Venture Exchange on November 14, 2024

Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) — Viridian Metals Inc. (TSXV:VRDN) (the “Company”) is pleased to provide an update to its press release dated November 6, 2024 in order to confirm that its common shares will open for trading on the TSX Venture Exchange on November 14, 2024 under the ticker symbol “VRDN”. While the Company had initially anticipated trading to commence on or about November 8, there was a technical issue experienced with SEDAR+ which delayed the public release of the Company’s filing statement dated October 28, 2024. The filing statement, as well as all of the material documents relating to the Company’s qualifying transaction are available for consultation under the Company’s SEDAR+ profile. Tyrell...

Continue reading

UPDATE – embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 26, 2024, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes...

Continue reading

Mirasol Resources Closes Private Placement Financing

VANCOUVER, British Columbia, Nov. 12, 2024 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol”) is pleased to announce the closing of the previously announced and upsized non-brokered private placement financing. The Company issued 11,335,132 Units (the “Units”) at a price of $0.45 per Unit for aggregate gross proceeds of $5,100,809.40. (the “Offering”). Each Unit is comprised of one (1) common share and one-half of one (1/2) non-transferable common share purchase warrant (the “Warrant”), with each whole Warrant entitling the holder to purchase one additional common share at a price of $0.60 for a period of twelve (12) months from closing of the Offering.   Proceeds of the Offering will be used to advance exploration, including drilling, at the Company’s flagship Sobek Project in the...

Continue reading

Home BancShares, Inc. to Participate in Fireside Chat at Stephens Annual Investment Conference – (Time Update)

CONWAY, Ark., Nov. 12, 2024 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), and its wholly-owned subsidiary, Centennial Bank (“Centennial”), announced that it would participate in a Fireside Chat during the Stephens Annual Investment Conference being held November 19, 2024. The Company will present at 1:00 p.m. CT (2:00 p.m. ET), on Tuesday, November 19, 2024. The Fireside Chat can be accessed live using the following link: https://wsw.com/webcast/stph35/homb/1819690. A replay will be available from the webcast link for 90 days following the live presentation at the following link: https://wsw.com/webcast/stph35/homb/1819690. Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail...

Continue reading

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma. Presented data supporting RTNova (CLD-400), the company’s systemic antitumor virotherapy platform, at the International Oncolytic Virotherapy Conference (IOVC) in Rotterdam, Netherlands, the Society for Immunotherapy of Cancer (SITC) Annual Meeting, and at Immuno US 2024 in San Diego, California. Raised $2 million in a registered direct offering and concurrent private placement. SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today reported its operating and financial results for the third quarter ended September 30, 2024, and reviewed recent...

Continue reading

Extendicare Announces 2024 Third Quarter Results and Early Redemption of 2025 Debentures

MARKHAM, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2024, and the Company announced that it is exercising its option to redeem all of the outstanding $126.5 million principal amount of 2018-1 5.00% convertible unsecured subordinated debentures (TSX: EXE.DB.C) (the “2025 Debentures”). Third Quarter 2024 Highlights Adjusted EBITDA(1) excluding out-of-period items increased by $13.5 million or 64.9% to $34.3 million, largely driven by rate increases in long-term care (“LTC”) and home health care and volume growth in home health care and managed services. Home health care average daily volume (“ADV”) grew to 30,181, up 10.2% from Q3 2023. SGP third-party and joint venture serviced beds increased 11.4%...

Continue reading

Tandy Leather Factory Reports Third Quarter 2024 Results

FORT WORTH, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the third fiscal quarter of 2024. Highlights from Third Quarter 2024: Revenues were $17.4 million, down 1.1% from 2023 Operating loss of $0.3 million Net loss of $0.1 million, down from net income of $0.6 million in 2023 Gross margins of 57.8%, down from 62.4% in 2023 Operating expenses $10.3 million, up 2.3% from 2023 Adjusted EBITDA* of $0.2 million Ended quarter with $10.1 million of cash and cash equivalents Tandy Leather Factory’s third quarter sales were $17.4 million in 2024, down from $17.5 million in 2023. Third quarter 2024 gross profit was $10.0 million, down from $10.9 million in 2023. Third quarter saw an operating loss of $0.3 million, down from operating income of $0.9...

Continue reading

Oriental Culture Holding LTD Announces First Half Year of 2024 Unaudited Financial Results

HONG KONG, Nov. 12, 2024 (GLOBE NEWSWIRE) — Oriental Culture Holding LTD. (“OCG” or the “Company”) (NASDAQ: OCG), a leading online provider of collectibles and artwork e-commerce services, today announced its unaudited financial results for the six months ended June 30, 2024. First Half Year of 2024 Financial Highlights Total revenues were approximately $0.4 million for the six months ended June 30, 2024, compared with the total revenues of approximately $0.8 million for the six months ended June 30, 2023. Gross profit was approximately $0.3 million for the six months ended June 30, 2024, compared with approximately gross profit of $0.6 million for the six months ended June 30, 2023. Gross margin was 65.8% for the six months ended June 30, 2024, compared with a gross margin of 76.0% for the six months ended June 30, 2023. Loss...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.